ICD is showing strong performance. This is interpreted as being influenced by the news that Absolix, an investment company of SKC, will receive a subsidy of 100 billion KRW from the U.S. government, the first for a semiconductor materials and components company.
As of 10:04 AM on the 24th, ICD is trading at 9,860 KRW, up 3.03% compared to the previous day.
According to foreign media, the U.S. Department of Commerce announced on the same day that it will provide Absolix with $75 million (approximately 102 billion KRW) under the Semiconductor Act.
The subsidy recipient is Absolix Covington Glass Substrate Plant 1 located in Georgia. The subsidy Absolix receives accounts for 25% of the total investment cost of $300 million. The first plant, which can produce 12,000㎡ annually, was recently completed and has begun trial operations.
Absolix is a subsidiary established in 2021 as a joint venture between SKC and Applied Materials (AMAT) in the U.S., focusing on glass substrates used in cutting-edge semiconductor packaging as its main product.
Using glass to make substrates allows them to be thinner than when using plastic, which can increase data processing speed and power efficiency. This is why glass substrates are considered a 'game changer' for high-speed processing of large volumes of data such as artificial intelligence (AI).
Meanwhile, ICD has been recognized in the display equipment market for its HDP (High Density Plasma) etching equipment, which has a higher plasma density than general dry etching equipment. It is also known that ICD’s dry etching equipment has been delivered to Absolix.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
